How Can 5-HT3 Receptor Antagonists Exert Analgesic Properties?
Abstract
No Abstract
Zahedi H, Maleki A, Rostami Gh. Ondansetron pretreatment reduces pain on injection of propofol. Acta Medica Iranica 2012;50(4):239-43
Färber L, Haus U, Späth M, Drechsler S. Physiology andpathophysiology of the 5-HT3 receptor. Scand J Rheumatol 2004;33:2–8.
Fiebich BL, Akundi RS, Lieb K, Candelario‐Jalil E, Gmeiner D, Haus U, Müller W, Stratz T, Muñoz E.Antiinflammatory effects of 5-HT3 receptor antagonists in lipopolysaccharide-stimulated primary human monocytes. Scand. J. Rheumatol 2004;119:28–32.
Seidel MF, Fiebich BL, Ulrich-Merzenich G, Candelario- Jalil E, Koch FW, Vetter H. Serotonin mediates PGE2 overexpression through 5-HT2A and 5-HT3 receptor subtypes in serum-free tissue culture of macrophage-like synovial cells. Rheumatol 2008;28:1017–22.
Samborski W, Stratz T, Mackiewicz S, Müller W. Intraarticulartreatment of arthritides and activated osteoarthritis with the 5-HT3 receptor antagonist tropisetron. A doubleblind study compared with methylprednisolone. Scand J Rheumatol 2004;119:51-4.
MauraG, Carlo Andrioli G, Cavazzani P, Raiteri M. 5-Hydroxytryptamine 3 receptors sited on cholinergic axon terminals of human cerebral cortex mediate inhibition of acetylcholine release. J Neurochem 1994;58:2334-7.
| Files | ||
| Issue | Vol 50, No 4 (2012) | |
| Section | Original Article(s) | |
| Keywords | ||
| No Keywords | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
